Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

  • Showing results for herman bernardo. Your search for Hermano Bernardo retrieved no results.
1.

Fellows perspective of HPB training in Latin America.

Domínguez-Rosado I, Espinoza JL, Alvarez FA, Vintimilla A, Quintero M, Barzallo D, Pekolj J, Gondolesi G, Schelotto PB, Herman P, Carneiro D'Albuquerque LA, Andraus W, Padilla J, Jarufe N, Chapa O, Mercado M, Chan C, Alseidi A.

HPB (Oxford). 2019 Jul 2. pii: S1365-182X(19)30566-0. doi: 10.1016/j.hpb.2019.05.016. [Epub ahead of print]

PMID:
31277838
2.

Laparoscopic vs. open left lateral sectionectomy: An update meta-analysis of randomized and non-randomized controlled trials.

Macacari RL, Coelho FF, Bernardo WM, Kruger JAP, Jeismann VB, Fonseca GM, Cesconetto DM, Cecconello I, Herman P.

Int J Surg. 2019 Jan;61:1-10. doi: 10.1016/j.ijsu.2018.11.021. Epub 2018 Nov 27. Review.

PMID:
30496866
3.

Preoperative strategies to improve resectability for hepatocellular carcinoma: a systematic review and meta-analysis.

Tustumi F, Ernani L, Coelho FF, Bernardo WM, Junior SS, Kruger JAP, Fonseca GM, Jeismann VB, Cecconello I, Herman P.

HPB (Oxford). 2018 Dec;20(12):1109-1118. doi: 10.1016/j.hpb.2018.06.1798. Epub 2018 Jul 26. Review.

PMID:
30057123
4.

Laparoscopy-assisted versus open and pure laparoscopic approach for liver resection and living donor hepatectomy: a systematic review and meta-analysis.

Coelho FF, Bernardo WM, Kruger JAP, Jeismann VB, Fonseca GM, Macacari RL, Cesconetto DM, D'Albuquerque LAC, Cecconello I, Herman P.

HPB (Oxford). 2018 Aug;20(8):687-694. doi: 10.1016/j.hpb.2018.02.379. Epub 2018 Mar 20.

PMID:
29571616
5.

Reconsidering the 'Decline' of Dental Student Empathy within the Course in Latin America.

Díaz-Narváez VP, Erazo Coronado AM, Bilbao JL, González F, Padilla M, Calzadilla-Nuñez A, Silva-Vetri MG, Arboleda J, Bullen M, Utsman R, Fajardo E, Alonso LM, Cervantes M, Varela T.

Acta Med Port. 2017 Nov 29;30(11):775-782. doi: 10.20344/amp.8681. Epub 2017 Nov 29.

6.

Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.

Moe SM, Chertow GM, Parfrey PS, Kubo Y, Block GA, Correa-Rotter R, Drüeke TB, Herzog CA, London GM, Mahaffey KW, Wheeler DC, Stolina M, Dehmel B, Goodman WG, Floege J; Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Investigators*.

Circulation. 2015 Jul 7;132(1):27-39. doi: 10.1161/CIRCULATIONAHA.114.013876. Epub 2015 Jun 9.

PMID:
26059012
7.

The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.

Parfrey PS, Drüeke TB, Block GA, Correa-Rotter R, Floege J, Herzog CA, London GM, Mahaffey KW, Moe SM, Wheeler DC, Kubo Y, Dehmel B, Goodman WG, Chertow GM; Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Investigators.

Clin J Am Soc Nephrol. 2015 May 7;10(5):791-9. doi: 10.2215/CJN.07730814. Epub 2015 Feb 20.

8.

Stenting and medical therapy for atherosclerotic renal-artery stenosis.

Cooper CJ, Murphy TP, Cutlip DE, Jamerson K, Henrich W, Reid DM, Cohen DJ, Matsumoto AH, Steffes M, Jaff MR, Prince MR, Lewis EF, Tuttle KR, Shapiro JI, Rundback JH, Massaro JM, D'Agostino RB Sr, Dworkin LD; CORAL Investigators.

N Engl J Med. 2014 Jan 2;370(1):13-22. doi: 10.1056/NEJMoa1310753. Epub 2013 Nov 18.

9.

Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease.

de Zeeuw D, Akizawa T, Audhya P, Bakris GL, Chin M, Christ-Schmidt H, Goldsberry A, Houser M, Krauth M, Lambers Heerspink HJ, McMurray JJ, Meyer CJ, Parving HH, Remuzzi G, Toto RD, Vaziri ND, Wanner C, Wittes J, Wrolstad D, Chertow GM; BEACON Trial Investigators.

N Engl J Med. 2013 Dec 26;369(26):2492-503. doi: 10.1056/NEJMoa1306033. Epub 2013 Nov 9.

10.

Thromboembolism prevention in surgery of digestive cancer.

Malafaia O, Montagnini AL, Luchese A, Accetta AC, Zilberstein B, Malheiros CA, Jacob CE, Quireze-Junior C, Bresciani CJ, Kruel CD, Cecconello I, Sad EF, Ohana JA, Aguilar-Nascimento JE, Manso JE, Ribas-Filho JM, Santo MA, Andreollo NA, Torres OJ, Herman P, Cuenca RM, Sallum RA, Bernardo WM.

Arq Bras Cir Dig. 2012 Oct-Dec;25(4):216-23. English, Portuguese.

11.

Peginesatide for anemia in patients with chronic kidney disease not receiving dialysis.

Macdougall IC, Provenzano R, Sharma A, Spinowitz BS, Schmidt RJ, Pergola PE, Zabaneh RI, Tong-Starksen S, Mayo MR, Tang H, Polu KR, Duliege AM, Fishbane S; PEARL Study Groups.

N Engl J Med. 2013 Jan 24;368(4):320-32. doi: 10.1056/NEJMoa1203166.

12.

Peginesatide in patients with anemia undergoing hemodialysis.

Fishbane S, Schiller B, Locatelli F, Covic AC, Provenzano R, Wiecek A, Levin NW, Kaplan M, Macdougall IC, Francisco C, Mayo MR, Polu KR, Duliege AM, Besarab A; EMERALD Study Groups.

N Engl J Med. 2013 Jan 24;368(4):307-19. doi: 10.1056/NEJMoa1203165.

13.

Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.

EVOLVE Trial Investigators, Chertow GM, Block GA, Correa-Rotter R, Drüeke TB, Floege J, Goodman WG, Herzog CA, Kubo Y, London GM, Mahaffey KW, Mix TC, Moe SM, Trotman ML, Wheeler DC, Parfrey PS.

N Engl J Med. 2012 Dec 27;367(26):2482-94. doi: 10.1056/NEJMoa1205624. Epub 2012 Nov 3.

14.

A novel antimicrobial and antithrombotic lock solution for hemodialysis catheters: a multi-center, controlled, randomized trial.

Maki DG, Ash SR, Winger RK, Lavin P; AZEPTIC Trial Investigators.

Crit Care Med. 2011 Apr;39(4):613-20. doi: 10.1097/CCM.0b013e318206b5a2.

PMID:
21200319

Supplemental Content

Loading ...
Support Center